0 followers
Abyssinia is altering the world's understanding of Alzheimer's Disease from diagnostic assays with the potential for early diagnosis to treatment approaches addressing novel disease causes. Abyssinia's lead candidate ABY-71A1 is a IgG1 mAb with a high specificity for toxic soluble amyloid oligomers,... Read more
Trebor R. Lawton
This company has no teams yet
Orchid
1 follower
Thermo Fisher Scientific
180 followers
Genentech
162 followers
Gilead Sciences
136 followers
Biogen
123 followers
Regeneron
104 followers
Vertex Pharmaceuticals
66 followers
Agilent Technologies
71 followers
Roivant Sciences
56 followers
BioMarin Pharmaceutical
37 followers
Verily Life Sciences
38 followers
Explore companies